The state government has awarded a contract for the first of two multi-storey car parks at the proposed Women and Babies Hospital while also acknowledging issues with congestion.
Kim Beazley-backed medtech company Orthocell has flagged an expedited expansion into several jurisdictions after strong early sales of its Remplir nerve repair technology.
The emergency department at St John of God Subiaco could be delayed up to two years after an application to extend the project’s stage three start deadline was submitted.
Bulk billing availability in WA has again declined, with a mere one in 16 WA GP clinics offering bulk billing in 2025, down from one in 10 last year, and one in five the year prior.
The time it takes to correctly diagnose endometriosis could be slashed from seven years to just a few weeks with a new, non-invasive test from Nedlands-based Proteomics International.
The state government moved to lock in contractors for the $1.8 billion Women and Babies’ Hospital in December, as it pushes to begin the project before the March election.
ASX-listed Botanix has shipped the first batch of Sofdra prescriptions, marking a milestone moment as it shifts towards becoming a revenue generating pharmaceuticals company.
A novel skin cancer diagnosis tool which was a finalist in Pilbara Health Challenge has been validated for the first time in humans, meaning skin biopsies could become a thing of the past.
A slew of reforms to the private health sector, including expanding access for maternity cover, have been floated today as part of a push to make private hospitals more viable.
Former 40under40 winner Angus Turner has been appointed to the FHRI advisory council, and a new $50 million funding commitment has been announced by the state.
WA-founded telehealth platform Hola Health has been named the state’s fastest growing tech company, with revenue growth of 1,521 per cent over the past three years.
One of Australia’s largest private hospital owners has announced it will terminate contracts with some of the country’s largest insurers, including HBF, after failing to agree to a rise in fees.
The state’s auditor general has recommended the Department of Health start a refresh of its digital strategy to tackle weaknesses in its management of emergency department data.
A promising new drug invented at UWA is set to begin clinical trials, which will observe whether, when paired with antibiotics, it can help treat chronic bacterial lung infections.
The revolutionary spray-on skin treatment developed in Perth by burns surgeon Fiona Wood is being reintroduced to the Australian market by Avita Medical.
The country’s inflation rate could be reduced by at least 2 per cent if Australia had an adequate COVID-19 response, a federal government-commissioned inquiry found.
Life insurance provider HCF Life could be set for penalties after the Federal Court found its ‘recover’ range of products was liable to mislead customers.
Perth-based biotechnology firm Orthocell has raised $17 million to take its Remplir nerve regeneration product to the world's biggest healthcare market.
While networking at a Business News function last year, Revo Fitness founder Andrew Holder struck up a conversation with Lifeline WA chief executive officer Lorna MacGregor.
Western Australia now accounts for more than two thirds of St John of God Health Care revenue, up nine per cent this year alone to see total revenue hit $2.2 billion.
ANALYSIS: The evolving nature of global conflict has kept veterans support service providers on their toes, as they adapt to meet needs in a rapidly shifting world.
